Cann Group (ASX: CAN) has taken a major step forward in expanding access to its Botanitech range of medicinal cannabis products, signing supply agreements with 11 Chemist Warehouse outlets in Queensland.
Key Highlights
- New distribution partnership: Cann will supply its Botanitech medicinal cannabis products to selected Chemist Warehouse pharmacies.
- On-demand supply model: Products will be available upon request in line with scripts issued under the TGA’s Special Access Scheme (SAS) and Authorised Prescriber (AP) scheme.
- Potential for further expansion: While the agreements cover 11 stores for now, this marks the beginning of a broader collaboration between Cann Group and one of Australia’s most recognised pharmacy brands.
CEO Commentary
Cann Group CEO Jenni Pilcher welcomed the deal, saying:
“We are thrilled to partner with Chemist Warehouse, one of Australia’s most trusted retail brands. This collaboration marks the beginning of a promising relationship, and we look forward to working closely with Chemist Warehouse and their network of franchisees to drive mutual success and growth.”
Why This Matters
This agreement significantly enhances patient access to medicinal cannabis in Queensland, making it easier for those with prescriptions to obtain GMP-manufactured, Australian-grown cannabis products. It also strengthens Cann Group’s presence in the high-growth Australian cannabis market, leveraging Chemist Warehouse’s extensive pharmacy network.
With a state-of-the-art cultivation and manufacturing facility in Mildura, Cann Group is well-positioned to scale production and meet growing demand.
